GLP1R and amyloidosis: It reshapes the gut microbiota structure and activates the GLP-1/GLP-1R pathway, thereby reducing amyloid deposition, enhancing synaptic plasticity, and alleviating cognitive dysfunction (Gao et al., 2023).